Answers are grounded in this paper and cite their sources.
Human Platelet Lysate (hPL) is a platelet-derived and growth factor-rich supplement for cell culture. It can be prepared from surplus platelet concentrates initially intended for transfusion. Amotosalen-based photochemical pathogen inactivation of platelet concentrates is used in a number of blood establishments worldwide to minimize the risk of pathogen transmission from donor to patient.
No takes yet. Share an insight, caveat, or question.
Delabie et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: